UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Update on Poly(ADP-ribose)polymerase‑1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy

Journal of medicinal chemistry, 2016-11, Vol.59 (21), p.9575-9598

2016

Volltextzugriff (PDF)

Autotrophic antimonate bio-reduction using hydrogen as the electron donor

Water research (Oxford), 2016-01, Vol.88, p.467-474

2016

Volltextzugriff (PDF)

Marine-derived angiogenesis inhibitors for cancer therapy

Marine Drugs, 2013-03, Vol.11 (3), p.903-933

2013

Volltextzugriff (PDF)

Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (20), p.5363-5373

2012

Volltextzugriff (PDF)

Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter

Cell death & disease, 2020-01, Vol.11 (1), p.71, Article 71

2020

Volltextzugriff (PDF)

New microtubulin inhibitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis

Cancer letters, 2018-03, Vol.416, p.57-65

2018

Volltextzugriff (PDF)

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine

Cell death & disease, 2019-07, Vol.10 (8), p.557-13, Article 557

2019

Volltextzugriff (PDF)

The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial

Trials, 2022-05, Vol.23 (1), p.379-11, Article 379

2022

Volltextzugriff (PDF)

A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction

Investigational new drugs, 2020-06, Vol.38 (3), p.700-713

2020

Volltextzugriff (PDF)

Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury

Purinergic signalling, 2016-03, Vol.12 (1), p.89-101

2016

Volltextzugriff (PDF)

In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer

Evidence-based complementary and alternative medicine, 2018-01, Vol.2018 (2018), p.1-14

2018

Volltextzugriff (PDF)

Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

Stem cell research, 2021-03, Vol.51, p.102175-102175, Article 102175

2021

Volltextzugriff (PDF)

Adenosine and the Regulation of Metabolism and Body Temperature

Advances in Pharmacology, 2011, Vol.61, p.77-94

2011

Volltextzugriff (PDF)

Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy

Biochemical pharmacology, 2024-05, Vol.223, p.116198, Article 116198

2024

Volltextzugriff (PDF)

Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells

Molecular cancer research, 2022-12, Vol.20 (12), p.1785-1798

2022

Volltextzugriff (PDF)

The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity

Biochemical and biophysical research communications, 2024-07, Vol.716, p.150011, Article 150011

2024

Volltextzugriff (PDF)

Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors

Journal of medicinal chemistry, 2019-09, Vol.62 (18), p.8642-8663

2019

Volltextzugriff (PDF)

Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells

Oncotarget, 2015-06, Vol.6 (18), p.16031-16042

2015

Volltextzugriff (PDF)

Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44

Molecular cancer therapeutics, 2016-07, Vol.15 (7), p.1495-1503

2016

Volltextzugriff (PDF)

Proteasome inhibitors reduce CD73 expression partly via decreasing p-ERK in NSCLC cells

Life sciences (1973), 2023-11, Vol.332, p.122129-122129, Article 122129

2023

Volltextzugriff (PDF)

Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1

Biochemical pharmacology, 2021-03, Vol.185, p.114435, Article 114435

2021

Volltextzugriff (PDF)

Poly(ADP-ribose)polymerase (PARP) Inhibition and Anticancer Activity of Simmiparib, a New Inhibitor Undergoing Clinical Trials

Cancer letters, 2017-02, Vol.386, p.47-56

2017

Volltextzugriff (PDF)

New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis

Biochemical pharmacology, 2018-08, Vol.154, p.255-264

2018

Volltextzugriff (PDF)

MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189

Molecular cancer therapeutics, 2014-06, Vol.13 (6), p.1480-1491

2014

Volltextzugriff (PDF)

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

Oncotarget, 2017-01, Vol.8 (3), p.4156-4168

2017

Volltextzugriff (PDF)

1 – 25 von 718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(573)
Mit Volltextzugriff
(633)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

An Update on Poly(ADP-ribose)polymerase‑1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy

Autotrophic antimonate bio-reduction using hydrogen as the electron donor

Marine-derived angiogenesis inhibitors for cancer therapy

Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II

Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter

New microtubulin inhibitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine

The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial

A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction

Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury

In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer

Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

Adenosine and the Regulation of Metabolism and Body Temperature

Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy

Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells

The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity

Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors

Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells

Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44

Proteasome inhibitors reduce CD73 expression partly via decreasing p-ERK in NSCLC cells

Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1

Poly(ADP-ribose)polymerase (PARP) Inhibition and Anticancer Activity of Simmiparib, a New Inhibitor Undergoing Clinical Trials

New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis

MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

Suchergebnisse filtern